About Pramana
Pramana is a digital pathology company that has developed what it calls Digital Pathology 2.0 - a generational advancement in whole slide imaging technology. The company's flagship products are the Spectral family of scanners, which feature autonomous operation capable of handling most slide types without user intervention, including challenging specimens. Pramana's innovative approach separates slide handling mechanisms from scan heads, offering modular and scalable solutions that allow labs to customize their setup and quickly upgrade capacity as needs grow. The technology is built on a pioneering volumetric imaging method that replicates the fine-focus function of optical microscopes, backed by a portfolio of granted U.S. patents. Key differentiators include built-in inline quality assurance with fully autonomous rescanning, edge AI capability to execute multiple feature description algorithms in real time during scanning, and compatibility with diverse specimen types including tissue biopsies, cytology samples, bone marrow, microbiology slides, and wet mounts. The company addresses critical pain points in traditional digital pathology including high manual quality control burden, underutilized scanner capacity, and slow cloud-based image analysis. In August 2024, Pramana was acquired by Evident (formerly Olympus Scientific Solutions), expanding Evident's digital pathology portfolio. The company's solutions are designed for anatomic pathology, cytopathology, hematopathology, clinical pathology, and microbiology applications, serving healthcare organizations and research institutions globally.
Clinical Focus
Medical conditions and clinical areas addressed by Pramana.
Who It Serves
Milestones & Awards
Recent Milestones
Acquired by Evident in August 2024; Health Canada authorization for SpectralM and SpectralHT Cubiq scanners in July 2024; Moffitt Cancer Center deployment in October 2024; Siemens Healthineers collaboration at Klinikum Ludwigshafen in September 2024
Key Partnerships
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 45 →
Aiforia
Aiforia provides AI-powered digital pathology solutions for clinical diagnostics and research. The company offers cloud-based deep learning tools and CE-IVD marked clinical suites for analyzing pathology images across multiple cancer types, serving pathologists, researchers, and diagnostic laboratories worldwide.
Aignostics
Aignostics develops AI-powered pathology solutions for precision medicine, specializing in tumor microenvironment analysis from H&E-stained whole slide images. The company serves life sciences companies and academic researchers with foundation models and custom analytics services.
Aiosyn
Aiosyn develops AI-powered computational pathology software that integrates into standard digital pathology workflows. The company specializes in deep learning solutions for cancer and chronic kidney disease diagnostics, serving clinical laboratories, biopharma, and CROs.
AIxMed
AIxMed develops AI-powered computational cytology platforms for cancer detection and diagnosis. The company's flagship product AIxURO analyzes urine cytology for bladder cancer, with additional platforms in development for thyroid, cervical, and lung cancer screening.
Akoya Biosciences
Akoya Biosciences, now part of Quanterix, provides spatial biology solutions for high-plex tissue analysis. The company develops instruments, assays, and software for spatial proteomics research, enabling researchers to map biomarkers at single-cell resolution in tissue samples.
Caris Life Sciences
Caris Life Sciences is a leading precision medicine company that provides comprehensive molecular profiling for cancer patients. The company combines genomic, transcriptomic, and proteomic data with AI to deliver personalized treatment insights for oncologists and patients.
CellaVision
201-500 employees
CellaVision is a world-leading provider of digital hematology microscopy solutions covering analyzers, instruments, reagents, and software. The company automates workflows in hematology laboratories of all sizes for human and animal blood and body fluid sample analysis.
Clever Culture Systems
Clever Culture Systems develops AI-powered automated microbiology culture plate reading technology for pharmaceutical and clinical laboratories. Their flagship product, APAS Independence, automates the imaging, interpretation, and reporting of microbial growth on culture plates.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.